Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ying Shiuan Lee"'
Autor:
Tulika Arora, Udo Wegmann, Anup Bobhate, Ying Shiuan Lee, Thomas U. Greiner, Daniel J. Drucker, Arjan Narbad, Fredrik Bäckhed
Publikováno v:
Molecular Metabolism, Vol 5, Iss 8, Pp 725-730 (2016)
Objective: The enteroendocrine hormone glucagon-like peptide 1 (GLP-1) is an attractive anti-diabetic therapy. Here, we generated a recombinant Lactococcus lactis strain genetically modified to produce GLP-1 and investigated its ability to improve gl
Externí odkaz:
https://doaj.org/article/b048ec4f1b7d4a9d9cb7601cb75249e3
Autor:
Ying Shiuan Lee, Filipe De Vadder, Valentina Tremaroli, Anita Wichmann, Gilles Mithieux, Fredrik Bäckhed
Publikováno v:
Molecular Metabolism, Vol 5, Iss 4, Pp 263-270 (2016)
Objective: Insulin-like peptide 5 (INSL5) is a recently identified gut hormone that is produced predominantly by L-cells in the colon, but its function is unclear. We have previously shown that colonic expression of the gene for the L-cell hormone GL
Externí odkaz:
https://doaj.org/article/8e9619ea778a485daf502188634d15a9
Autor:
Christina N. Heiss, Randy J. Seeley, Ying Shiuan Lee, Fredrik Bäckhed, Anna Håkansson Gladh, Daniel J. Drucker, Louise Mannerås-Holm, Julia Serrano-Lobo, Louise E. Olofsson
Publikováno v:
Heiss, C N, Mannerås-Holm, L, Lee, Y S, Serrano-Lobo, J, Håkansson Gladh, A, Seeley, R J, Drucker, D J, Bäckhed, F & Olofsson, L E 2021, ' The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism ', Cell Reports, vol. 35, no. 8, 109163 . https://doi.org/10.1016/j.celrep.2021.109163
Mice lacking a microbiota are protected from diet-induced obesity. Previous studies have shown that feeding a Western diet causes hypothalamic inflammation, which in turn can lead to leptin resistance and weight gain. Here, we show that wild-type (WT
Autor:
Anup Bobhate, Arjan Narbad, Udo Wegmann, Tulika Arora, Thomas U. Greiner, Fredrik Bäckhed, Ying Shiuan Lee, Daniel J. Drucker
Publikováno v:
Molecular Metabolism, Vol 5, Iss 8, Pp 725-730 (2016)
Molecular Metabolism
Molecular Metabolism
Objective The enteroendocrine hormone glucagon-like peptide 1 (GLP-1) is an attractive anti-diabetic therapy. Here, we generated a recombinant Lactococcus lactis strain genetically modified to produce GLP-1 and investigated its ability to improve glu
Autor:
Fredrik Bäckhed, Valentina Tremaroli, Anita Wichmann, Filipe De Vadder, Gilles Mithieux, Ying Shiuan Lee
Publikováno v:
Molecular Metabolism
Molecular Metabolism, Vol 5, Iss 4, Pp 263-270 (2016)
Molecular Metabolism, Vol 5, Iss 4, Pp 263-270 (2016)
Objective Insulin-like peptide 5 (INSL5) is a recently identified gut hormone that is produced predominantly by L-cells in the colon, but its function is unclear. We have previously shown that colonic expression of the gene for the L-cell hormone GLP
Autor:
Dongya Zhang, Yan Xia, Dorota Ewa Kotowska, Jianfeng Zhang, Valentina Tremaroli, Xun Xu, Jovanna Dahlgren, Jun Wang, Ye Yin, Yangqing Peng, Josefine Roswall, Huijue Jia, Ying Shiuan Lee, Karsten Kristiansen, Lise Madsen, Camilla Colding, Fredrik Bäckhed, Yin Li, Petia Kovatcheva-Datchary, Junhua Li, Muhammad Tanweer Khan, Liang Xiao, Qiang Feng, Stefan Bergman, Jumana Y. Al-Aama, Huanzi Zhong, Hailiang Xie
Publikováno v:
Cell Host & Microbe. 17:690-703
SummaryThe gut microbiota is central to human health, but its establishment in early life has not been quantitatively and functionally examined. Applying metagenomic analysis on fecal samples from a large cohort of Swedish infants and their mothers,
Autor:
Ruth E. Ley, Erik Larsson, Omry Koren, Intawat Nookaew, Jens Nielsen, Fredrik Bäckhed, Valentina Tremaroli, Ashwana D. Fricker, Ying Shiuan Lee
Publikováno v:
Gut
Background The gut microbiota has profound effects on host physiology but local hostemicrobial interactions in the gut are only poorly characterised and are likely to vary from the sparsely colonised duodenum to the densely colonised colon. Microorga
Publikováno v:
Rapid Communications in Mass Spectrometry. 24:729-741
Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia in China since the 1980s. However, information relevant to in vivo metabolism of meisoindigo is absent so far. In this study, in vivo circulato
Publikováno v:
International journal of oncology. 45(4)
Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia (CML) in China since the 1980s. In the present study, the in vitro antileukemic activity of meisoindigo was investigated in acute promyelocytic
Publikováno v:
Rapid communications in mass spectrometry : RCM. 24(6)
Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia in China since the 1980s. However, information relevant to in vivo metabolism of meisoindigo is absent so far. In this study, in vivo circulato